I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| microglial cell | 4 studies | 21% ± 4% | |
| oligodendrocyte | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| microglial cell | 4 studies | 21% ± 4% | |
| oligodendrocyte | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of SALL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 4259.69 | 89 / 89 | 93% | 40.42 | 836 / 901 |
| brain | 93% | 1805.11 | 2460 / 2642 | 99% | 65.82 | 697 / 705 |
| liver | 100% | 3945.22 | 226 / 226 | 92% | 21.24 | 373 / 406 |
| thymus | 100% | 5740.73 | 652 / 653 | 84% | 51.10 | 508 / 605 |
| uterus | 98% | 3319.95 | 167 / 170 | 19% | 5.85 | 88 / 459 |
| ovary | 86% | 814.61 | 155 / 180 | 14% | 3.06 | 61 / 430 |
| bladder | 62% | 679.33 | 13 / 21 | 2% | 0.30 | 9 / 504 |
| skin | 26% | 224.82 | 471 / 1809 | 19% | 5.39 | 91 / 472 |
| stomach | 38% | 171.69 | 136 / 359 | 2% | 0.19 | 7 / 286 |
| intestine | 39% | 227.27 | 374 / 966 | 2% | 0.25 | 8 / 527 |
| prostate | 30% | 139.56 | 73 / 245 | 1% | 0.07 | 3 / 502 |
| eye | 0% | 0 | 0 / 0 | 10% | 1.16 | 8 / 80 |
| esophagus | 0% | 1.45 | 7 / 1445 | 9% | 1.26 | 17 / 183 |
| pancreas | 7% | 27.06 | 22 / 328 | 2% | 0.21 | 3 / 178 |
| heart | 8% | 34.61 | 69 / 861 | 0% | 0 | 0 / 0 |
| lung | 0% | 0.66 | 1 / 578 | 7% | 0.99 | 85 / 1155 |
| breast | 5% | 15.68 | 21 / 459 | 1% | 0.16 | 14 / 1118 |
| adrenal gland | 1% | 2.74 | 2 / 258 | 4% | 0.63 | 10 / 230 |
| adipose | 3% | 9.73 | 33 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 0% | 4.57 | 1 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.77 | 3 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.44 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001657 | Biological process | ureteric bud development |
| GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
| GO_0008406 | Biological process | gonad development |
| GO_0072092 | Biological process | ureteric bud invasion |
| GO_0007507 | Biological process | heart development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0048566 | Biological process | embryonic digestive tract development |
| GO_0060173 | Biological process | limb development |
| GO_0042733 | Biological process | embryonic digit morphogenesis |
| GO_0001822 | Biological process | kidney development |
| GO_0003281 | Biological process | ventricular septum development |
| GO_0072073 | Biological process | kidney epithelium development |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0021553 | Biological process | olfactory nerve development |
| GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0061034 | Biological process | olfactory bulb mitral cell layer development |
| GO_0030325 | Biological process | adrenal gland development |
| GO_0021889 | Biological process | olfactory bulb interneuron differentiation |
| GO_0031129 | Biological process | inductive cell-cell signaling |
| GO_0021983 | Biological process | pituitary gland development |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0003337 | Biological process | mesenchymal to epithelial transition involved in metanephros morphogenesis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0010369 | Cellular component | chromocenter |
| GO_0000792 | Cellular component | heterochromatin |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0008013 | Molecular function | beta-catenin binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SALL1 |
| Protein name | Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1) SALL1 protein Sal-like protein 1 Spalt like transcription factor 1 |
| Synonyms | SAL1 ZNF794 |
| Description | FUNCTION: Transcriptional repressor involved in organogenesis. Plays an essential role in ureteric bud invasion during kidney development. . |
| Accessions | Q14CE9 ENST00000566102.1 Q9NSC2 ENST00000685868.1 [Q9NSC2-1] H3BSM9 ENST00000440970.6 [Q9NSC2-1] H3BQ32 ENST00000251020.9 [Q9NSC2-1] ENST00000570206.2 [Q9NSC2-2] ENST00000690502.1 A0A8I5KRF8 ENST00000570206 |
